Hosted by: 

Biotech Growth / Late Growth Stage CEO Forum

A unique, powerful and valuable space for the candid sharing of experience between 30 of the sector’s emerging and innovative post-series A Biotech executives. Like-minded Executives are joined by 2-3 appropriate and value-matched industry stakeholders and partners to provide expertise, experience and best practice on strategic areas of focus. Case studies will also be delivered by a number of executives in the room who have enjoyed success or navigated key challenges in their pursuit of company growth.

A pre-registration only, exclusive hollow square forum where all participants are active discussants.

Qualifier: Company executives must be post-series A and from a therapeutic-indication Biotech company

Session Outline: 1pm - 3.15pm and 3.30pm – 5.30pm followed by CEO Drinks and Dinner

Case studies include but not limited to:

• A keynote presentation with views on investment trends and deal making
• Case study: considerations for a commercialization model: how to optimize value to patients and stakeholders
• Case study: taking your products through the clinic / clinical / R&D strategies
• Case study: internationalization as a strategy to maximise the global potential of clinical pipelines
• Case study: challenges in securing later stage investment
• Case study: later-stage licensing deals / partnerships to scale your business
• Case study: preparing commercial go-to-market, strategies and activities

• Approx. 20mins of hollow square discussion around each of the above topics
• 1hr of general macro challenge discussion not restricted to valuation, alternative growth strategies, asset commercial strategies and research partnerships

For enquiries contact:

Matt Pullan, SVP, Business Development
matt@lsxleaders.com 
+44 (0) 203 637 5908